These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7909535)

  • 1. Evaluation of a DUR intervention: a case study of histamine antagonists.
    Zimmerman DR; Collins TM; Lipowski EE; Sainfort F
    Inquiry; 1994; 31(1):89-101. PubMed ID: 7909535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled letter intervention to change prescribing behavior: results of a dual-targeted approach.
    Collins TM; Mott DA; Bigelow WE; Zimmerman DR
    Health Serv Res; 1997 Oct; 32(4):471-89. PubMed ID: 9327814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacists' reactions to the Wisconsin Medicaid drug-use review program.
    Brown CM; Lipowski EE
    Am J Hosp Pharm; 1993 Sep; 50(9):1898-902. PubMed ID: 7907839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug utilization review of sedative/hypnotic agents in Texas Medicaid patients. Texas Medicaid Vendor Drug Program Drug Utilization Review Board.
    Seltzer JK; Kurt TL; Knodel LC; Dean B; Burch C
    J Am Pharm Assoc (Wash); 2000; 40(4):495-9. PubMed ID: 10932458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
    Lucas LM; Gerrity MS; Anderson T
    Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of anti-epileptic drugs in fee-for-service Wisconsin Medicaid.
    Mergener MA; Carr RM
    WMJ; 2006 Sep; 105(6):36-9. PubMed ID: 17042418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug education. Moving ahead the fourth year.
    Seibert DJ
    Pa Med; 1997 Jan; 100(1):22-4, 26. PubMed ID: 9014488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of drug utilization reviews on the quality of in-hospital prescribing: a quasi-experimental study.
    Grégoire JP; Moisan J; Potvin L; Chabot I; Verreault R; Milot A
    BMC Health Serv Res; 2006 Mar; 6():33. PubMed ID: 16536865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderly.
    Starner CI; Norman SA; Reynolds RG; Gleason PP
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):11-9. PubMed ID: 19281936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A qualitative study to explore influences on general practitioners' decisions to prescribe new drugs.
    Jacoby A; Smith M; Eccles M
    Br J Gen Pract; 2003 Feb; 53(487):120-5. PubMed ID: 12817357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of educational outreach to improve evidence-based prescribing in Medicaid: a cautionary tale.
    Zillich AJ; Ackermann RT; Stump TE; Ambuehl RJ; Downs SM; Holmes AM; Katz B; Inui TS
    J Eval Clin Pract; 2008 Oct; 14(5):854-60. PubMed ID: 19018918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked increase in proton pump inhibitors use in Australia.
    Hollingworth S; Duncan EL; Martin JH
    Pharmacoepidemiol Drug Saf; 2010 Oct; 19(10):1019-24. PubMed ID: 20623646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational prescribing: practice audit and drug switch in dyspepsia management.
    Dott AG; Johnson L
    Int J Clin Pract; 1999 Dec; 53(8):599-603. PubMed ID: 10692753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting costs by targeting prescribing practices.
    Edouard L; Rawson NS
    CMAJ; 1994 Jul; 151(1):14-5. PubMed ID: 8004553
    [No Abstract]   [Full Text] [Related]  

  • 15. Determining physicians' knowledge and attitudes when prescribing drugs to treat gastrointestinal disorders.
    Soons KR; Lynch T; Seagrave M; Rolley L
    Clin Perform Qual Health Care; 1997; 5(2):94-8. PubMed ID: 10167220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a drug utilization review program on high-risk use of prescription controlled substances.
    Daubresse M; Gleason PP; Peng Y; Shah ND; Ritter ST; Alexander GC
    Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):419-27. PubMed ID: 23881609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of an educational intervention for secondary prevention of myocardial infarction on Medicaid drug use and cost.
    Zuckerman IH; Weiss SR; McNally D; Layne B; Mullins CD; Wang J
    Am J Manag Care; 2004 Jul; 10(7 Pt 2):493-500. PubMed ID: 15298236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of prescription practices and of the rational use of medicines in Niger].
    Mallet HP; Njikam A; Scouflaire SM
    Sante; 2001; 11(3):185-93. PubMed ID: 11641083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA; Kuppermann M; Richter JE
    Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A successful field-based pharmacy program.
    Miller W
    Med Interface; 1995 Feb; 8(2):71-4, 77. PubMed ID: 10140634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.